Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Determining the right time to start retirement planning is crucial for your financial future. Learn when to take the first step.
24,040 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
A government-backed move accelerates commercialization of quantum tech, and three ETFs are steering investors through...
Insiders are weighing a bold scenario where SpaceX could climb to as much as $10 trillion by 2030, potentially overta...
Geopolitical risk, a wary AI sector, and stronger payrolls are reshaping market bets, just as SpaceX readies its IPO ...
As AI stocks drive gains, traders debate whether equal-weighted ETFs like RSP can outpace SPY’s cap-weighted edge. He...
Prices whey protein ingredients have surged in U.S. markets as demand climbs and supply tightens, sending 80% concent...
As crypto markets rally and property assets gain value, Trump’s fortune climbs $6.5B, highlighting a shifting mix of ...
Strong U.S. jobs data rekindled concerns about liquidity in crypto markets. The resilient jobs market keeps policy in...
The NHL is evaluating a Texas expansion with Dan Friedkin, potentially in Houston or Austin. A six-month term sheet o...
A Wisconsin pensioner challenges a $313 trespass ticket on Lake Michigan shoreline, highlighting a growing clash over...
A looming 10-year treasury signal could temper SCHD's 2026 rally as rising yields threaten valuations for dividend-fo...
European lawmakers are pushing for an ethics inquiry into FIFA chief Gianni Infantino after allegations that politica...